Anson Funds Management as of Dec. 31, 2018
Portfolio Holdings for Anson Funds Management
Anson Funds Management holds 54 positions in its portfolio as reported in the December 2018 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Tilray (TLRY) | 57.7 | $99M | 1.4M | 70.54 | |
| Proshares Tr Ii ultra vix short | 9.4 | $16M | 198k | 81.73 | |
| Schlumberger (SLB) | 8.0 | $14M | 382k | 36.08 | |
| Walt Disney Company (DIS) | 4.1 | $7.1M | 65k | 109.65 | |
| Citigroup (C) | 3.5 | $6.1M | 117k | 52.06 | |
| Goldman Sachs (GS) | 3.1 | $5.4M | 33k | 167.05 | |
| Alphabet Inc Class A cs (GOOGL) | 3.0 | $5.2M | 5.0k | 1045.00 | |
| Argan (AGX) | 0.9 | $1.6M | 43k | 37.85 | |
| Brookfield Property Reit Inc cl a | 0.9 | $1.5M | 95k | 16.12 | |
| Catasys | 0.7 | $1.1M | 121k | 9.37 | |
| Aeterna Zentaris | 0.6 | $987k | 336k | 2.94 | |
| Mack-Cali Realty (VRE) | 0.5 | $852k | 44k | 19.59 | |
| Hudson Pacific Properties (HPP) | 0.4 | $735k | 25k | 29.04 | |
| Seanergy Maritime Hldgs Corp a | 0.4 | $705k | 1.4M | 0.50 | |
| Brookfield Asset Management | 0.4 | $614k | 16k | 38.38 | |
| SL Green Realty | 0.4 | $612k | 7.8k | 78.97 | |
| Valeritas Hldgs | 0.3 | $571k | 1.7M | 0.33 | |
| Rexahn Pharmaceuticals | 0.3 | $565k | 607k | 0.93 | |
| Invitation Homes (INVH) | 0.3 | $552k | 28k | 20.07 | |
| Simon Property (SPG) | 0.3 | $520k | 3.1k | 167.74 | |
| Aquinox Pharmaceuticals | 0.3 | $474k | 219k | 2.16 | |
| Newlink Genetics Corporation | 0.2 | $429k | 282k | 1.52 | |
| Oncosec Med | 0.2 | $412k | 643k | 0.64 | |
| smith Micro Software | 0.2 | $409k | 227k | 1.80 | |
| Heat Biologics Inc -redh | 0.2 | $413k | 422k | 0.98 | |
| Liberty Property Trust | 0.2 | $377k | 9.0k | 41.89 | |
| Tetraphase Pharmaceuticals | 0.2 | $380k | 336k | 1.13 | |
| Davidstea (DTEAF) | 0.2 | $385k | 326k | 1.18 | |
| Uxin Ltd ads | 0.2 | $374k | 77k | 4.86 | |
| Infinity Pharmaceuticals (INFIQ) | 0.2 | $346k | 293k | 1.18 | |
| Francescas Hldgs Corp | 0.2 | $297k | 306k | 0.97 | |
| Trillium Therapeutics, Inc. Cmn | 0.2 | $298k | 174k | 1.71 | |
| Cytori Therapeutics Inc *w exp 05/28/202 | 0.2 | $301k | 1.0M | 0.29 | |
| Resonant | 0.2 | $280k | 211k | 1.33 | |
| Foamix Pharmaceuticals | 0.2 | $284k | 79k | 3.59 | |
| Viveve Med | 0.1 | $263k | 250k | 1.05 | |
| Clearside Biomedical (CLSD) | 0.1 | $250k | 233k | 1.07 | |
| Celldex Therapeutics | 0.1 | $246k | 1.2M | 0.20 | |
| American Campus Communities | 0.1 | $207k | 5.0k | 41.40 | |
| Gtx Inc Del | 0.1 | $207k | 265k | 0.78 | |
| Safe T Group | 0.1 | $190k | 64k | 2.96 | |
| Geron Corporation (GERN) | 0.1 | $171k | 171k | 1.00 | |
| Arcadia Biosciences | 0.1 | $175k | 55k | 3.17 | |
| Tracon Pharmaceuticals | 0.1 | $158k | 250k | 0.63 | |
| Edge Therapeutics | 0.1 | $78k | 243k | 0.32 | |
| Shine | 0.1 | $94k | 161k | 0.58 | |
| Synthetic Biologics | 0.1 | $88k | 157k | 0.56 | |
| Diffusion Pharmaceuticals In | 0.0 | $66k | 33k | 1.99 | |
| Tonix Pharmaceuticals Hldg C | 0.0 | $68k | 31k | 2.18 | |
| Phio Pharmaceuticals Corp *w exp 12/21/202 | 0.0 | $72k | 217k | 0.33 | |
| Vascular Biogenics | 0.0 | $45k | 46k | 0.98 | |
| Medigus Ltd *w exp 07/23/202 | 0.0 | $55k | 21k | 2.62 | |
| Xg Technology | 0.0 | $29k | 94k | 0.31 | |
| Inspiremd Inc *w exp 03/14/202 | 0.0 | $40k | 250k | 0.16 |
